Hera Health Solutions is a pharmaceutical device company specializing in the research, development, and commercialization of long term treatments through proprietary biodegradable implants by using existing generic drugs in combination with already FDA-approved structural materials.
Our first product - Eucontra has a fully working prototype and is finalizing preclinical trials to prep for full FDA submission and approval.
Hera's first product, Eucontra aims to join and disrupt the worldwide contraceptive market valued at a $14B industry. Moreover, the long acting drug delivery market which can be utilized through our drug delivery platform is estimated to be valued at over $800B.
Problem or Opportunity
Offering quality and controlled medication over long periods of time is troublesome and requires invasive procedures. Current solutions on the market make it necessary for an expensive and complicated removal procedures. These procedures often leave behind heavy bruising, scarring, and even lost foreign objects in the body.
Solution (product or service)
Proprietary biodegradable drug delivery implants created by using existing generic drugs in combination with already FDA approved structural materials will deliver trusted medication over extended periods of time.
Advantages or differentiators
There are currently no products on the market that directly address the removal issuess of the contraceptive arm implant. The pricing of our product is competitive and offer a non invasive, effective, and discreet form.
Currently raising $1.25 MM Series Seed Round - Lead Investor Secured with leading Healthcare VC
Technology will be marketed and sold as pharmaceutical products that align with already existing reimbursement codes.
Money will be spent on
1. Non- GLP Preclinical Testing
2. PIND FDA Submission
3. WHO Pre Approval Submission
4. Prepare Clinical Study Preparation